key: cord-0772654-4wed8e4p authors: Szarfer, Jorge Luis; Puente, Luciana; Bono, Leandro; Estrella, María Laura; Doppler, Eugenia; Napoli Llobera, Mariano; Arce, María Patricia; Borri, Karina Alejandra; Fiandesio, Mariana Elisa; Ferraris, Marta Josefina; Gagliardi, Juan title: Impact of a Prolonged COVID-19 Lockdown on Patterns of Admission, Mortality and Performance Indicators in a Cardiovascular Intensive Care Unit date: 2021-02-23 journal: Int J Qual Health Care DOI: 10.1093/intqhc/mzab029 sha: 860a9bba9ebf3f87e385afb1588e3c2559383c3f doc_id: 772654 cord_uid: 4wed8e4p BACKGROUND: The effects of an early and prolonged lockdown during the COVID-19 pandemic on cardiovascular intensive care units is not well established. This study analyses patterns of admission, mortality and performance Indicators in a cardiovascular intensive care unit before and during the Argentine lockdown in the COVID-19 pandemic. METHODS: This is a retrospective observational cross-sectional study of all consecutive patients aged 18 years or more admitted to the Cardiac Intensive Care Unit at a high-volume reference hospital in Buenos Aires, Argentina comparing hospitalization rates, primary causes of admission, inpatient utilisation indicators, pharmacy supplies expenditures, and in-hospital mortality between March 5 and July 31, 2020 with two corresponding control periods in 2019 and 2018. RESULTS: We included 722 patients [mean age of 61.6 (SD 15.5) years; 237 (32.8%)] were females. Overall hospitalisations dropped 53.2% (95%CI: 45.3, 61.0%) from 295.5 patients/year over the periods 2018/2019 to 137 patients in 2020. Cardiovascular disease-related admissions dropped 59.9%, while admission for noncardiac causes doubled its prevalence from 9.6% over the periods 2018/2019 to 22.6% in the study period (P<0.001). In the period 2020, the bed occupancy rate fell from 82.2% to 77.4%, and the bed turnover rate dropped 50% from 7.88 to 3.91 monthly discharges/bed. The average length of stay doubled from 3.26 to 6.75 days, and the turnover interval increased from 3.8 to 8.39 days in 2020. Pharmacy supplies expenditures per discharge increased 134% along with a rise in antibiotics usage from 6.5 to 11.4 vials/ampoules per discharge (P<0.02). Overall mortality increased from 7% (n=41) to 13.9% (n=19) (P=0.008) at the expense of noncardiac related admissions (3.6% to 19.4%, P=0.01). CONCLUSIONS: This study found a significant reduction in overall and cardiovascular disease-related causes of admission to the cardiac intensive care unit, worse performance indicators and increased in-hospital mortality along the first five months of the early and long-lasting COVID-19 lockdown in Argentina. These results highlight the need to foster public awareness concerning the risks of avoiding hospital attendance. Moreover, health systems should follow strict screening protocols to prevent potential biases in the admission of patients with critical conditions unrelated to the COVID-19 pandemic. This study aims to analyse patterns of admission, mortality and performance indicators in a cardiovascular Intensive care unit before and during the lockdown in the COVID-19 pandemic. We performed a single-centre cross-sectional study analysing the number of hospitalisations, causes of admission, in-hospital mortality and key performance indicators in a Cardiovascular Intensive Care Unit (CICU) in one of the four high volume acute care reference state hospitals serving a catchment population of approximately three million people. We retrospectively included all consecutive patients admitted to the CICU in the Division of Cardiology at the Hospital General de Agudos Dr. Cosme Argerich in Buenos Aires, Argentina. This reference centre, along with three others and thirty referral hospitals, is part of a net of thirty-four state hospitals distributed radially in the city. The study period encompasses the interval between the first confirmed case of COVID-19, March 5, and July 31 2020. We compared bed availability, hospitalisation rates, causes of admission, in-hospital mortality and performance indicators between the study period and two control periods corresponding to the same dates in 2019 and 2018. Primary objectives included: 1. CICU overall admission and discharge rates; 2. primary causes of admission; 3. performance indicators analysis (inpatient utilisation indicators and pharmacy supplies expenditures); and 4. in-hospital mortality.  bed occupancy rate (BOR): number of beds effectively occupied (beddays)/number of beds ×100;  bed turnover rate (BTR): number of discharges (including deaths) in a given period/number of beds during that period;  average length of stay (ALOS): total inpatient days of care/total discharges; and  Turnover interval (TOI): (available staffed bed days -occupied bed days)/inpatient discharges. Pharmacy supplies expenditures are expressed in rounded whole numbers in local currency (ARS) using July 2020 purchase prices for both periods. To simplify the analysis, we grouped supplies according to their primary therapeutic effect in antibiotics, vasopressor drugs, inotropic agents, hypnotics and analgesics, personal protective equipment, disposables supplies, or others. We analysed efficiency by estimating pharmacy supplies expenditures per discharge (ARS/discharge index). For comparison, and given the heterogeneity of conditions admitted to the CICU, we classified the primary cause of admission into the following groups: Categorical variables are described as absolute and relative frequencies and compared using the chi-square test. Quantitative variables are presented as mean and standard deviation (SD) or as the median and interquartile range [IQR 25-75] according to its distribution. Normality was checked using the Shapiro-Wilk test. Means and 95% confidence intervals (95% CI) were determined for data obtained from 2018 and 2019 and compared with raw data from 2020. Based on the range of reduction of acute coronary syndromes and cardiovascular admissions observed in previous studies (25-60%) (3) (4) (5) (6) (7) (8) (9) , we calculated a sample size of 124 patients in each group to achieve a power level 9 of 80% for a 25.2% relative risk reduction in the rate of cardiovascular admissions with a selected two-sided alpha level of 0.05 in a chi-squared test. Observed variations are expressed as percentages and 95% CI of reduction or increase from historical levels. A P-value<0.05 was considered significant. For data processing, we used Epi Info version 7.2. Under the Hospital General de Agudos "Cosme Argerich" ethics committee guidelines for clinical research, no approval requirement is necessary for this type of protocol; i.e., observational cross-sectional study without personal information disclosures. All participants signed an informed consent form. Diagnostic parameters and clinical assessments were performed according to the 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation (10) Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (11) . Data were collected fulfilling the 'Epi-cardio' database questionnaire (Epicrisis v. 3.0) at each CICU discharge (12) . This cross-sectional study included 722 patients, 237 (32.8%) female, with a mean age of 61.6 (SD 15.5) years. There were no differences in age The decrease in cardiovascular disease-related admissions was primarily associated with PCL, PCS, AMI and other types of ACS. Table 1 shows the reduction in CICU hospitalisation rates according to the primary cause of admission. Regarding inpatient utilisation indicators, we observed a slight reduction in the (Table 3 ). We found a decrease in overall (53.2%) and cardiovascular (59.9%) CICU admissions with a 10.7% increase in hospitalisations for non-cardiac reasons (doubling its prevalence), worse performance indicators such as a 50% drop in bed turnover and almost a two-fold increase in mortality. To our knowledge, this is the first report analysing causes of admission, inhospital mortality and key-performance indicators in a CICU at a high-volume Although the fall in admission rates was evident in every group, it markedly affected patients with AMI as a consequence of a 65% decrease in primary percutaneous interventions at the Cath Lab and a similar reduction (60%) in ACS without ST-elevation admissions. It was due to imposed protocols delaying invasive intervention to prioritise human resources in the health care system. Other countries have applied similar protocols; for example, the UK, Austria, Italy and the USA reduced ACS admissions by 39.4%, 26.5%, 40% and 38%, respectively. 4,6-8 Likewise, Northern Italy cut down non-urgent percutaneous procedures above 50%. 9 The increase observed in ALOS differs from other series in which a reduction was detected. 3 Two factors may explain this rise and the drop in BTR. Although there was a marked decrease in admissions usually associated with a short length of stay, e.g., PCL monitoring, AMI and other types of ACS, the increase in the prevalence of patients admitted with non-cardiac diseases requiring complex and long-lasting therapies, i.e., a prolonged stay, altered both inpatient utilisation indicators. The increase in ALOS and TOI with a stable BOR seems to be inconsistent. The analysis of Figure 1 The severity of non-cardiac patients explains by itself the high death rate observed throughout the period 2020 as has been already observed when a health care system focuses on COVID-19 delaying the medical response to less severe patients. 7 Despite the lower rate of admissions, CICU costs remained high. Other authors have reported similar findings. 13 Pharmacy supplies expenditures per discharge 15 far doubled the two previous years' amounts. The requirement of antibiotics, analgesics, vasoactive and hypnotic drugs, and personal protective equipment is responsible for this increment. The increase in the prevalence of admissions for non-cardiac reasons explains the antibiotics, analgesic, and hypnotic drugs overspending. COVID-19 pandemic is responsible for the personal protective equipment increment. These results highlight the need to foster public awareness concerning the risks of avoiding hospital attendance, particularly in most vulnerable groups. Moreover, health systems should follow strict screening protocols to prevent potential biases in the admission of patients with critical conditions unrelated to the COVID-19 pandemic. This cross-sectional study found a significant reduction in CICU admissions, a shift in admission diagnoses, worse performance indicators and increased inhospital mortality in a high-volume acute care reference centre during the first five months of the enduring Argentine COVID-19 lockdown. There is no conflict of interests. The data that supports the findings of this study cannot be shared publicly for the privacy of individuals that participated in the study. The data will be shared on reasonable request to the corresponding author. The monthly variation of inpatient utilisation indicators over 2018/2019 remained stable. In 2020, the bed occupancy rate dropped almost 50% in June and rose sharply up to 100% in July while the turnover internal reached the peak in June when the bed turnover rate was at the lowest level. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic Case rates, treatment approaches, and outcomes in acute myocardial infarction during the coronavirus disease 2019 Pandemic Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era The Covid-19 pandemic and the incidence of acute myocardial infarction Impact of the COVID-19 pandemic on admissions for acute coronary syndrome: review of the literature and single-center experience ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes in patients presenting without persistent STsegment elevation of the European Society of Cardiology Chief Complaints, Procedures, Outcomes and Discharge Treatment Plan of 54,000 Patients Admitted to Cardiovascular Care Units in Argentina After Six Years of the Epi-Cardio Registry American Hospital Association. Hospitals and health systems face unprecedented financial pressures due to COVID-19